GenSci094

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GenSci094, covering 2024-12-03 to 2025-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference

See pricing